Aneuploidies - whole chromosome gains or losses - are the foundation of prenatal screening. Trisomy 21, 18, and 13 are the conditions every NIPT laboratory must reliably detect. But validation has always faced the same constraint: where do you find enough positive samples to prove your assay works? At Eabha